Approximately 50% of RDD lesions harbor mutations in genes in the MAPK/ERK pathway, including KRAS, NRAS, MAP2K1, ARAF, CSF1R, and rarely BRAF V600E [35, 37]. The gene discussed is KRAS; the disease is sinus histiocytosis with massive lymphadenopathy.